These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8723120)

  • 21. Selection bias and the use of controls with malformations in case-control studies of birth defects.
    Lieff S; Olshan AF; Werler M; Savitz DA; Mitchell AA
    Epidemiology; 1999 May; 10(3):238-41. PubMed ID: 10230831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
    Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with congenital malformations in Thailand.
    Suwatanaviroj A; Ratrisawadi V
    J Med Assoc Thai; 1996 Sep; 79(9):545-9. PubMed ID: 8996981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens.
    Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF
    Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland.
    Artama M; Ritvanen A; Gissler M; Isojärvi J; Auvinen A
    Int J Epidemiol; 2006 Apr; 35(2):280-7. PubMed ID: 16280367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based case-control study of oral griseofulvin treatment during pregnancy.
    Czeizel AE; Métneki J; Kazy Z; Puho E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):827-31. PubMed ID: 15315593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid embryopathy.
    Lammer EJ; Chen DT; Hoar RM; Agnish ND; Benke PJ; Braun JT; Curry CJ; Fernhoff PM; Grix AW; Lott IT
    N Engl J Med; 1985 Oct; 313(14):837-41. PubMed ID: 3162101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes after first-trimester vaginitis drug therapy.
    Rosa FW; Baum C; Shaw M
    Obstet Gynecol; 1987 May; 69(5):751-5. PubMed ID: 3574801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
    JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital malformations in the newborn--a prospective study.
    Mishra PC; Baveja R
    Indian Pediatr; 1989 Jan; 26(1):32-5. PubMed ID: 2788132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns and trends of multiple congenital anomalies in birth defects surveillance systems.
    Khoury MJ; Waters GD; Erickson JD
    Teratology; 1991 Jul; 44(1):57-64. PubMed ID: 1957264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the effect of drug intake during pregnancy based on the Monitoring Surveillance of the Pathogenesis of Congenital Anomalies].
    Gréger J; Czeizel E; Rácz J
    Orv Hetil; 1992 Feb; 133(7):407-8, 413-5. PubMed ID: 1542501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
    Seto A; Einarson T; Koren G
    Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of pregnancy after discontinuation of isotretinoin.
    Dai WS; Hsu MA; Itri LM
    Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to prescribed drugs in pregnancy and association with congenital malformations.
    Bracken MB; Holford TR
    Obstet Gynecol; 1981 Sep; 58(3):336-44. PubMed ID: 7266953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teratogenicity of progestogens given during the first trimester of pregnancy.
    Katz Z; Lancet M; Skornik J; Chemke J; Mogilner BM; Klinberg M
    Obstet Gynecol; 1985 Jun; 65(6):775-80. PubMed ID: 3158848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Teratological counseling in Israel].
    Ornoy A; Arnon J
    Harefuah; 1991 May; 120(10):567-73. PubMed ID: 1937190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.